Cargando…
Letter to the editor: COVID-19: how accurate are seroprevalence studies?
Autor principal: | Kadkhoda, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393853/ https://www.ncbi.nlm.nih.gov/pubmed/32734860 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.30.2001374 |
Ejemplares similares
-
Authors’ response: COVID-19: how accurate are seroprevalence studies?
por: Cassaniti, Irene, et al.
Publicado: (2020) -
Letter to the Editor: The Interpretation of COVID-19 Seroprevalence Study Should Be Cautious
por: Lee, Jaehyeon, et al.
Publicado: (2020) -
Letter to the Editor: Neurohospitalist and COVID-19
por: Duong, Lisa, et al.
Publicado: (2020) -
Letter to the Editor [Letter]
por: Félix, Sylvie
Publicado: (2021) -
Letter to the editor: how the COVID-19 pandemic has changed outpatient diagnosis in the andrological setting
por: Mazzilli, R., et al.
Publicado: (2021)